ArticleMolecular cancer therapeutics2024

Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity.

Peter Cornelius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.